PLOS Special Collection: Successful approaches to HIV care

August 03, 2020

On July 27 2020, the U.S. Department of Health and Human Services' (HHS) Health Resources and Services Administration (HRSA) launched a Special Collection of manuscripts across the open-access journals PLOS Medicine and PLOS ONE, highlighting Ryan White HIV/AIDS Program's (RWHAP) innovative approaches for data utilization and engagement of people with HIV who are not in care and not virally suppressed.

The Collection addresses how HRSA's RWHAP uses data to facilitate care at state and local levels; clinical, population, and geographic differences among RWHAP clients; RWHAP implementation science initiatives; healthcare workforce; healthcare systems differences in outcomes; and other key strategies such as pre-exposure prophylaxis (PrEP).

"For three decades, HRSA's Ryan White HIV/AIDS Program has played a critical role in the United States' response to ending the HIV epidemic," said HRSA Administrator Tom Engels. "More than half a million people - representing more than half of people with diagnosed HIV in the U.S. - receive services through the RWHAP annually. In 2018, approximately 87 percent of RWHAP patients receiving medical care were virally suppressed, exceeding the national average of approximately 65 percent."

This Special Collection is an important resource to inform programs about successful approaches to HIV care and to highlight the RWHAP's specialized experience. The Collection addresses issues such as challenges of sustainability, analysis of cost effectiveness, and the scalability of interventions. The authors describe HRSA's collaborative efforts both internally with members of other operating divisions within HHS and externally with partners from various grant recipients across the country. These collaborative efforts allow for data sharing and obtaining perspectives that provide additional insights into and solutions for the issues, as well as novel and innovative approaches to HIV care and treatment, for advancing the national effort to end the HIV epidemic.
About HRSA: HRSA implements the RWHAP, which provides a comprehensive system of HIV primary medical care, medication, and essential support services for low-income people with HIV. First authorized in 1990, the RWHAP funds grants to states, cities/counties, and local community-based organizations to provide HIV care and treatment services, improve health outcomes, and reduce HIV transmission among hard-to-reach populations. HRSA's Ryan White HIV/AIDS Program plays an important role in the Administration's Ending the HIV Epidemic: A Plan for America initiative, which aims to reduce the number of new HIV infections in the United States by 90 percent by 2030.

For more information about HRSA's Ryan White HIV/AIDS Program, visit

In your coverage please use this URL to provide access to the launched Special Collection:

Funding: Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services.

Competing Interests: The authors have declared that no competing interests exist.


Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to